文献速递免疫规划传染病防控与疫情报告

登革热疫苗接种的潜在影响:来自两项四价登革热疫苗大规模III期试验的见解

Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine.
PubMed 文献 · Vaccine · 2016-09-03

基于两项四价登革热疫苗III期效力研究的数据,采用年龄结构、宿主-媒介、血清型特异性房室模型,评估在亚洲五国和拉丁美洲五国接种疫苗对登革热病例的群体影响。结果显示所有接种方案在疫苗引入后头10年及以后均显著减少登革热病例,常规接种联合大规模补种可快速降低疾病负担。

要点

  • 所有探索的接种方案在疫苗引入后头10年及以后均显著减少登革热病例。
  • 最有效接种年龄随传播强度变化,9岁在所有设定中接近最有效年龄。
  • 常规接种联合大规模补种可在疫苗引入后快速降低登革热负担。

核心结论

  • 分析表明,在登革热地方性流行国家,接种登革热疫苗可显著降低登革热的公共卫生影响。

研究设计与样本

  • 采用年龄结构、宿主-媒介、血清型特异性房室模型,参数基于两项四价登革热疫苗III期效力研究的数据估计。
  • 研究设定为参与试验的五个亚洲国家(印度尼西亚、马来西亚、菲律宾、泰国、越南)和五个拉丁美洲国家(巴西、哥伦比亚、洪都拉斯、墨西哥和波多黎各)。

主要发现

  • 所有探索的接种方案在疫苗引入后头10年及以后均显著减少登革热病例。
  • 最有效接种年龄随传播强度变化,9岁在所有设定中接近最有效年龄。
  • 常规接种联合大规模补种可在疫苗引入后快速降低登革热负担。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A tetravalent dengue vaccine demonstrated its protective efficacy in two phase III efficacy studies. Results from these studies were used to derive vaccination impact in the five Asian (Indonesia, Malaysia, Philippines, Thailand, Vietnam) and the five Latin American countries (Brazil, Colombia, Honduras, Mexico and Puerto Rico) participating in these trials. METHODS: Vaccination impact was investigated with an age-structured, host-vector, serotype-specific compartmental model. Parameters related to vaccine efficacy and levels of dengue transmission were estimated using data collected during the phase III efficacy studies. Several vaccination programs, including routine vaccination at different ages with and without large catch-up campaigns, were investigated. RESULTS: All vaccination programs explored translated into significant reductions in dengue cases at the population level over the first 10years following vaccine introduction and beyond. The most efficient age for vaccination varied according to transmission intensity and 9years was close to the most efficient age across all settings. The combination of routine vaccination and large catch-up campaigns was found to enable a rapid reduction of dengue burden after vaccine introduction. CONCLUSION: Our analysis suggests that dengue vaccination can significantly reduce the public health impact of dengue in countries where the disease is endemic.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Coudeville L, Baurin N, L'Azou M, et al. Potential impact of dengue vaccination: Insights from two large-scale phase III trials with a tetravalent dengue vaccine. Vaccine. 2016. PMID: 27601343. doi:10.1016/j.vaccine.2016.08.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。